These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37709999)

  • 21. Posttraumatic Growth After MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder.
    Gorman I; Belser AB; Jerome L; Hennigan C; Shechet B; Hamilton S; Yazar-Klosinski B; Emerson A; Feduccia AA
    J Trauma Stress; 2020 Apr; 33(2):161-170. PubMed ID: 32073177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.
    Feduccia AA; Jerome L; Mithoefer MC; Holland J
    Psychopharmacology (Berl); 2021 Feb; 238(2):581-588. PubMed ID: 33221932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.
    Mithoefer MC; Wagner MT; Mithoefer AT; Jerome L; Doblin R
    J Psychopharmacol; 2011 Apr; 25(4):439-52. PubMed ID: 20643699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
    Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM
    JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
    Wagner MT; Mithoefer MC; Mithoefer AT; MacAulay RK; Jerome L; Yazar-Klosinski B; Doblin R
    J Psychopharmacol; 2017 Aug; 31(8):967-974. PubMed ID: 28635375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
    Tucker P; Zaninelli R; Yehuda R; Ruggiero L; Dillingham K; Pitts CD
    J Clin Psychiatry; 2001 Nov; 62(11):860-8. PubMed ID: 11775045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults.
    Maples-Keller JL; Norrholm SD; Burton M; Reiff C; Coghlan C; Jovanovic T; Yasinski C; Jarboe K; Rakofsky J; Rauch S; Dunlop BW; Rothbaum BO
    J Psychopharmacol; 2022 Mar; 36(3):368-377. PubMed ID: 35166140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial.
    Mathew SJ; Vythilingam M; Murrough JW; Zarate CA; Feder A; Luckenbaugh DA; Kinkead B; Parides MK; Trist DG; Bani MS; Bettica PU; Ratti EM; Charney DS
    Eur Neuropsychopharmacol; 2011 Mar; 21(3):221-9. PubMed ID: 21194898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil.
    Jardim AV; Jardim DV; Chaves BR; Steglich M; Ot'alora G M; Mithoefer MC; da Silveira DX; Tófoli LF; Ribeiro S; Matthews R; Doblin R; Schenberg EE
    Braz J Psychiatry; 2021; 43(2):181-185. PubMed ID: 32638920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Double-Blind, Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Posttraumatic Stress Disorder and Comorbid Depression.
    Ramaswamy S; Driscoll D; Reist C; Smith LM; Albers LJ; Rose J; Nguyen L; Monga V; Doria R; Hollifield M
    Prim Care Companion CNS Disord; 2017 Aug; 19(4):. PubMed ID: 28858440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [MDMA-assisted therapy for PTSD].
    Thorarinsdottir H; Gudmundsdottir B; Sigurdsson E
    Laeknabladid; 2024 May; 110(5):254-261. PubMed ID: 38713560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDMA-assisted psychotherapy for the treatment of PTSD: A systematic review and meta-analysis of randomized controlled trials (RCTs).
    Shahrour G; Sohail K; Elrais S; Khan MH; Javeid J; Samdani K; Mansoor H; Hussain SI; Sharma D; Ehsan M; Nashwan AJ
    Neuropsychopharmacol Rep; 2024 Oct; ():. PubMed ID: 39381877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
    Mithoefer MC; Wagner MT; Mithoefer AT; Jerome L; Martin SF; Yazar-Klosinski B; Michel Y; Brewerton TD; Doblin R
    J Psychopharmacol; 2013 Jan; 27(1):28-39. PubMed ID: 23172889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD.
    Lewis CR; Tafur J; Spencer S; Green JM; Harrison C; Kelmendi B; Rabin DM; Yehuda R; Yazar-Klosinski B; Cahn BR
    Front Psychiatry; 2023; 14():959590. PubMed ID: 36815187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder: Efficacy of a Glutamatergic Modulator for Antidepressant-Resistant Symptoms.
    Spangler PT; West JC; Dempsey CL; Possemato K; Bartolanzo D; Aliaga P; Zarate C; Vythilingam M; Benedek DM
    J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33113596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Prolonged Exposure Therapy, Sertraline Hydrochloride, and Their Combination Among Combat Veterans With Posttraumatic Stress Disorder: A Randomized Clinical Trial.
    Rauch SAM; Kim HM; Powell C; Tuerk PW; Simon NM; Acierno R; Allard CB; Norman SB; Venners MR; Rothbaum BO; Stein MB; Porter K; Martis B; King AP; Liberzon I; Phan KL; Hoge CW
    JAMA Psychiatry; 2019 Feb; 76(2):117-126. PubMed ID: 30516797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial.
    Rae Olmsted KL; Bartoszek M; Mulvaney S; McLean B; Turabi A; Young R; Kim E; Vandermaas-Peeler R; Morgan JK; Constantinescu O; Kane S; Nguyen C; Hirsch S; Munoz B; Wallace D; Croxford J; Lynch JH; White R; Walters BB
    JAMA Psychiatry; 2020 Feb; 77(2):130-138. PubMed ID: 31693083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo.
    Rothbaum BO; Davidson JR; Stein DJ; Pedersen R; Musgnung J; Tian XW; Ahmed S; Baldwin DS
    J Clin Psychiatry; 2008 Oct; 69(10):1529-39. PubMed ID: 19192435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
    Feder A; Costi S; Rutter SB; Collins AB; Govindarajulu U; Jha MK; Horn SR; Kautz M; Corniquel M; Collins KA; Bevilacqua L; Glasgow AM; Brallier J; Pietrzak RH; Murrough JW; Charney DS
    Am J Psychiatry; 2021 Feb; 178(2):193-202. PubMed ID: 33397139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD.
    Marseille E; Kahn JG; Yazar-Klosinski B; Doblin R
    PLoS One; 2020; 15(10):e0239997. PubMed ID: 33052965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.